Your browser doesn't support javascript.
loading
Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
Wu, Jiazhu; Xu, Xiaojing; Lee, Eun-Joon; Shull, Austin Y; Pei, Lirong; Awan, Farrukh; Wang, Xiaoling; Choi, Jeong-Hyeon; Deng, Libin; Xin, Hong-Bo; Zhong, Wenxun; Liang, Jinhua; Miao, Yi; Wu, Yujie; Fan, Lei; Li, Jianyong; Xu, Wei; Shi, Huidong.
Afiliación
  • Wu J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China.
  • Xu X; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
  • Lee EJ; Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
  • Shull AY; Georgia Prevention Institute, Augusta University, Augusta, GA 30912, USA.
  • Pei L; Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
  • Awan F; Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
  • Wang X; Department of Biochemistry & Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Choi JH; Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
  • Deng L; Division of Hematology, The Ohio State University, Columbus, OH, 43210, USA.
  • Xin HB; Georgia Prevention Institute, Augusta University, Augusta, GA 30912, USA.
  • Zhong W; Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
  • Liang J; Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.
  • Miao Y; Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.
  • Wu Y; Department of Statistics, University of Georgia, Athens, GA 30602, USA.
  • Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China.
  • Li J; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
  • Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China.
  • Shi H; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, 210029, China.
Oncotarget ; 7(26): 40558-40570, 2016 Jun 28.
Article en En | MEDLINE | ID: mdl-27302925
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Linfocitos T CD8-positivos / Epigénesis Genética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Linfocitos T CD8-positivos / Epigénesis Genética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos